Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Completes Acquisition of Genetix

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher has completed its ₤63.4 million ($102 million) acquisition of imaging products firm Genetix, which will now operate as part of Danaher subsidiary Leica Microsystems.

Danaher had announced its 85 pence per share bid to acquire the New Milton, UK-based firm in December.

The acquisition will bring together Genetix's expertise in imaging systems and software for research purposes with Leica's microsopes and other life science instruments. The Genetix business will operate as a separate business unit within Leica, and its products will continue to be marketed and sold through existing channels, said Wetzlar, Germany-based Leica.

"Genetix' extensive expertise will be invaluable for us," Stefan Traeger, managing director of the life science division of Leica Microsystems, said in a statement. "Their software capabilities, specifically in analytical software, will help us to make progress in the area of virtual microscopy which is a field we have only recently stepped into. In addition, Genetix' experience and market leading products in cell biology and genetics will expand our reach into the drug discovery and development markets."

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.